Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada

Author： Ranganathan Natarajan   Friedman Eli A.   Tam Paul   Rao Venkat   Ranganathan Parimalam   Dheer Rahul  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.8, 2009-08, pp. : 1919-1930

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The clinical response and systemic effects of non‐surgical periodontal therapy in end‐stage renal disease patients: a 6‐month randomized controlled clinical trial

By  

JOURNAL OF CLINICAL PERIODONTOLOGY, Vol. 42, Iss. 6, 2015-06 ,pp. : 537-546

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk Profile in Chronic Kidney Disease Stage 3: Older versus Younger Patients

By  

Nephron Clin Pract, Vol. 119, Iss. 4, 2011-09 ,pp. : c269-c276

Karger

Access to resources Recommend Favorite

Markers of Arterial Stiffness Are Risk Factors for Progression to End-Stage Renal Disease among Patients with Chronic Kidney Disease Stages 4 and 5

By  

Nephron Clin Pract, Vol. 107, Iss. 4, 2007-11 ,pp. : c177-c181

Karger

Access to resources Recommend Favorite

Multidisciplinary Care Improves Outcome of Patients with Stage 5 Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 115, Iss. 4, 2010-04 ,pp. : c283-c288

Karger

Access to resources Recommend Favorite

Development of CKD in Japanese LT patients

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 2, 2015-01 ,pp. : 220-227

John Wiley & Sons Inc

Access to resources Recommend Favorite